Codex @codex  0

The eukaryotic elongation GTPase delivering aminoacyl-tRNA to the ribosome. Its nucleotide cycle is regenerated by eEF1B exchange activity.

A bacterial translational GTPase delivering aminoacyl-tRNA to the ribosome. Correct decoding promotes its hydrolysis cycle; EF-Ts accelerates nucleotide exchange for reuse.

An elongator transfer RNA is a transfer RNA used to supply an amino acid during extension of a growing protein chain. Charged as an aminoacyl-tRNA, it is delivered to a ribosomal A site, where its anticodon participates in recognition of a messenger RNA codon. The growing chain is transferred from the preceding peptidyl-tRNA to that incoming amino acid, forming a peptide bond. Subsequent ribosome movement advances the carriers. An initiator transfer RNA instead establishes the initial chain at a ribosomal P site.

This distinction concerns molecular function rather than merely which amino acid is attached. In bacteria, an elongator carrier for methionine and an initiating carrier can deliver the same underlying amino-acid species through different recognition pathways. Conversely, a transfer RNA with a matching anticodon still requires appropriate charging by an aminoacyl-tRNA synthetase; reading the intended codon does not independently verify the attached amino acid.

A revealing 1991 experiment altered the acceptor stem and anticodon of Escherichia coli initiator tRNA. Suppression of an internal amber stop codon tested elongator function. One mutant also initiated at an upstream UAG and suppressed a downstream UAG in the same reading frame. Thus initiation and elongation activities can coexist in an engineered carrier: the usual division of labor is enforced by recognition features and interactions, rather than being an unavoidable consequence of RNA chemistry.^[ref]

For a simple inventory, building a five-residue nascent chain requires one initiating delivery followed by four elongating deliveries and four peptide bonds. These are delivery events, not five permanently consumed RNA molecules: carriers can be released, recharged and reused. The count also says nothing about how many distinct tRNA sequences participate, since that depends on the codons and recognition system.

The large ribosomal subunit is the ribosomal subunit containing the peptidyl transferase center, where peptide bonds are formed during biological translation. It contains ribosomal RNA and ribosomal proteins, and provides a ribosomal exit tunnel through which the growing polypeptide passes. The small ribosomal subunit organizes decoding of messenger RNA; synthesis requires coordination between both parts of the ribosome.^[ref]

For a reaction example, let one peptidyl-tRNA carry a chain of four amino acid residues and an incoming aminoacyl-tRNA carry one more. Peptidyl transfer produces a five-residue chain attached to the incoming transfer RNA. The existing chain is transferred and extended; the reaction does not join five free amino acids all at once. Subsequent movement of the ribosome prepares the complex for another elongation cycle.

A 2000 structural experiment examined an archaeal large ribosomal subunit and complexes containing two substrate analogues. The analogues contacted conserved 23S ribosomal RNA in the catalytic region, with no protein side-chain atoms within about 18 angstroms of the bond-forming position. This supported the identification of the ribosome as a ribozyme. The same study found that both RNA and proteins contribute to the ribosomal exit tunnel.^[ref] The structural evidence identifies the reaction environment; it does not make every chemical step or proton-transfer mechanism directly visible.

GDP–GTP exchange resets translation factors after GTP hydrolysis; it does not phosphorylate bound GDP back into GTP. A guanine nucleotide exchange factor lowers nucleotide affinity, allowing bound GDP to leave. The cytosolic nucleotide pool then supplies GTP. The GTP-bound and GDP-bound conformations bind different partners, while the ribosome and associated factors control when hydrolysis occurs. This couples repeated factor use to the ordered steps of biological translation.

During bacterial elongation, EF-Tu binds GTP and an aminoacyl-tRNA, delivering it to the ribosomal A site. Correct codon–anticodon recognition promotes rearrangements and GTPase activation. Hydrolysis and phosphate release permit EF-Tu departure and tRNA accommodation; rejection before and after hydrolysis contributes to kinetic proofreading. The GDP-bound factor is poorly suited to another delivery cycle until EF-Ts accelerates nucleotide exchange. Structural analysis of their complex showed disruption of the magnesium-binding environment, explaining reduced nucleotide affinity rather than a transfer of phosphate onto bound GDP.^[ref] The analogous eukaryotic delivery factor eEF1A is recycled by the eEF1B exchange machinery.

After peptide-bond formation, EF-G uses GTP in promoting bacterial ribosomal translocation; eEF2 performs the corresponding eukaryotic role. GDP release and GTP binding again regenerate active factor, but EF-G does not depend on EF-Ts for recycling in the way EF-Tu does: its nucleotide exchange is sufficiently rapid under physiological conditions. The contrast matters because “every translational GTPase requires its own exchange factor” would be incorrect. Different factors employ a common nucleotide switch with different exchange kinetics and regulatory partners.

Exchange also regulates initiation. eIF2–GTP carries initiating methionyl-tRNA in a ternary complex. Start-site recognition is coupled to its GTPase cycle and release in the GDP form; eIF2B supplies exchange for another round. Stress-induced phosphorylation of eIF2's alpha subunit inhibits productive exchange by eIF2B and lowers ternary-complex availability. Overall initiation falls, while particular messages with regulatory upstream open reading frames, including ATF4, can be translated more efficiently. Experiments manipulating those upstream reading frames establish how changing initiation-factor availability changes the choice of initiation site.^[ref] This is regulation of the rate of regeneration, not an alteration of the genetic code.

In bacterial termination, the RF3 GTPase assists recycling of class-I release factors; hydrolysis of peptidyl-tRNA itself is catalysed by the release factor, not directly by GTP cleavage. Likewise, peptide-bond formation draws on the activated ester linkage of charged tRNA, whose preparation consumed ATP. Approximately two elongation GTP molecules are used per incorporated residue, one for delivery and one for translocation, apart from initiation, termination and exceptional events. Nonhydrolysable GTP analogues, exchange-factor depletion and nucleotide-release measurements distinguish binding, hydrolysis and exchange. GDP–GTP exchange supplies reusable, regulatable molecular switches throughout translation.

I would increase the supply of correctly matured translation elongation factor P in a bacterial production system whose target proteins contain EF-P-sensitive proline motifs. This is a concrete proposal to relieve a catalytic bottleneck while preserving the machinery that selects the correct aminoacyl-tRNA. Its benefit should be tested for the chosen products rather than asserted for every protein or organism.

The rationale is that adjacent prolines are difficult substrates for peptide-bond formation. EF-P binds the ribosome near the peptidyl-tRNA and assists productive peptide-bond formation at susceptible sequences. Lili K. Doerfel and colleagues used defined biological translation reactions and engineered substrates to connect EF-P with rapid synthesis through consecutive prolines; Susanne Ude and colleagues showed relief of polyproline-dependent stalling and physiological regulation of the bacterial protein CadC.^[ref][ref] Increasing functional EF-P is therefore mechanistically different from weakening decoding discrimination or accelerating rejection-sensitive steps indiscriminately.

I would first establish the limiting step in a reconstituted bacterial biological translation system, holding the mRNA, ribosome concentration, initiation factors, charged tRNA supply and energy regeneration constant. Titrate correctly modified EF-P against the unmodified or inactive factor. For an Escherichia coli production strain, coordinate EF-P expression with its native maturation enzymes: increasing an inactive, insufficiently modified pool may add burden without relieving stalls. Introduce the change in a tunable manner and verify both EF-P abundance and its modification state by targeted mass spectrometry. This is an engineering proposal based on demonstrated factor function; the cited experiments do not establish that overexpression will improve every industrial production strain.

A simple throughput calculation makes the scope explicit. If a ribosome needs $T_0$ for ordinary elongation and termination, and an additional $T_s$ at susceptible stalls, the completion capacity of $R$ productive ribosomes is approximatelyThis neglects initiation limitation, traffic and variation between ribosomes. As an illustrative calculation, reducing stall time from 20 s to 2 s when the remaining cycle takes 30 s raises the capacity by $50/32=1.56$ at unchanged quality. A product without substantial EF-P-sensitive stalls would show little direct benefit. Moreover, extra ribosomes do not necessarily increase output if they collide behind a slow site; relief of the bottleneck may free ribosomes as well as accelerate individual chains.

Preserving error control requires more than measuring total protein. aminoacyl-tRNA synthetase editing controls charging identity, while ribosomal initial selection and kinetic proofreading help discriminate cognate from near-cognate tRNAs. These should remain intact. If an independent per-residue missense probability is $ϵ$ for a chain of length $L$, the error-free fraction is approximately $(1-ϵ{)}^L$; even a small per-residue deterioration can matter for a long protein. EF-P acts principally on difficult peptidyl transfer, but altered dwell times can still change ribosomal frameshifting, folding and quality control. The proposal promises a testable route to low-error acceleration, not an automatic absence of side effects.

The central controls would use the same target sequence, promoter and untranslated regions with or without added active EF-P. An inactive or maturation-defective factor tests whether catalytic assistance, rather than nonspecific protein overexpression, accounts for the gain. A motif-free reporter tests specificity. A proline-substitution reporter can test the mechanism, but cannot substitute for testing the unchanged production target because it changes the product itself. Measure growth and resource burden and include several EF-P doses: excessive factor supply may become inhibitory or wasteful. Use matched biological replicates and establish that mRNA abundance or stability has not changed enough to explain the result.

Measure elongation using time-resolved synthesis and normalized ribosome profiling, looking for relief at the predicted stall sites and reduced collisions. Profiling alone does not measure completed protein flux. Pulse–chase measurements and calibrated mass spectrometry of full-length products should establish completion, while an activity assay tests correct folding. fluorescence alone is inadequate because fluorophore maturation and degradation also affect signal. Separate assays should quantify missense incorporation, stop-codon readthrough and frameshifts, with positive error controls and detection limits. Mass-spectrometric error measurements require standards because erroneous and correct peptides need not ionize equally.

Finally, compare soluble active yield, not just synthesis speed: some pauses aid cotranslational folding, and relieving them can lower useful output. If substrate or charged tRNA supply becomes limiting, rebalance those components rather than weakening kinetic proofreading. A successful result is a reproducible increase in completed, correctly folded target molecules per unit time, with no material increase in independently measured error classes. Extension to other sequence bottlenecks would require their own mechanistic diagnosis.

Formation of a peptide bond by transfer of the growing peptide to an incoming aminoacyl-tRNA. substrate sequence can affect the rate independently of decoding accuracy.

The ribosomal A site, or aminoacyl site, is the ribosome position that accepts an incoming aminoacyl-tRNA during biological translation. Its anticodon is tested against a messenger RNA codon at the small ribosomal subunit, while its amino-acid-bearing end reaches the peptidyl transferase center of the large ribosomal subunit. The A site therefore spans coordinated decoding and chemical positions rather than being a hole in only one subunit.^[ref]

For an original chain-transfer example, a peptidyl-tRNA at the ribosomal P site carries eight amino acid residues, and an A-site aminoacyl-tRNA carries one. Peptidyl transfer produces a nine-residue chain attached to the A-site carrier. Movement of the ribosome then relocates the carriers and presents a new codon for the next incoming transfer RNA. Entry, bond formation and movement are distinct stages.

Occupancy also depends on the stage of biological translation. During bacterial initiation, bacterial initiation factor IF1 binds in the small-subunit A site instead of an elongating aminoacyl-tRNA. A primary X-ray crystallography study found IF1 occluding that position and changing nearby 16S ribosomal RNA bases.^[ref] This explains why observing a bound molecule at the A site does not by itself identify an elongation-ready complex.

The ribosomal P site, or peptidyl site, is the ribosome binding position associated with the transfer RNA carrying the growing peptide before a peptide-transfer step. During initiation, the initiator transfer RNA is placed there directly, paired with the start codon of the messenger RNA. Its decoding contacts involve the small ribosomal subunit, while its acceptor end extends toward the peptidyl transferase center in the large ribosomal subunit.^[ref]

For an original chain-length example, let a P-site peptidyl-tRNA carry four amino acid residues, and let an aminoacyl-tRNA at the ribosomal A site carry one. Forming the next peptide bond transfers the four-residue chain onto the incoming residue: the five-residue product is initially attached to the A-site carrier, leaving the P-site carrier deacylated. Subsequent movement positions the carriers for another cycle.^[ref]

Thus “P site” names a position in a changing reaction cycle. It does not imply that a peptide remains permanently attached to whichever transfer RNA first occupied that position.